CorrlensCorrlens
Correlate

Correlation Analysis

Johnson & Johnson vs Viatris Inc. Common Stock

JNJ vs VTRS

+0.338

Light positive

When one moves up, the other tends to follow.

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

VTRS logo

Viatris Inc. Common Stock

VTRS

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Market cap 15.6B · 30,000 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: JNJGray: VTRS36 of 1,254 points (sampled)

Who Moves First

JNJ leads VTRS by 6 days

JNJ tends to move before VTRS.

After testing 13 timing shifts, the strongest relationship was +0.348 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.657

12 periods · Return correlation when both series rose

Both Falling

+0.074

10 periods · Return correlation when both series fell

Diverging

-0.722

13 periods · Return correlation when series moved apart

R-Squared

11.4%

Share of variance in one series explained by the other.

Trend Agreement

59.9%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.288, 0.386]

Scatter

XY Regression

135.5140160180200220240252.66.9781012141616.44Johnson & JohnsonViatris Inc. Common StockData pointsFit (r = 0.338)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Series B

VTRS logo

Viatris Inc. Common Stock

VTRS

Market cap 15.6B · 30,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

41

Estimated crossover points between normalized spreads.

Slope

0.0325

Linear regression slope.

Intercept

5.8957

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 4 hours ago · ID: stock-jnj-vs-stock-vtrs-daily